---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-25-000152"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2025-05-05T23:59:59+00:00"
generated_at: "2026-05-22T17:57:21.937850+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers Q1 revenue $586M (+111% YoY), net income $49.5M, raises EBITDA guidance

## Summary
- Revenue $586M (+111% YoY); net income $49.5M (up 345% YoY); Adj. EBITDA $91.1M (up 182% YoY).
- Subscribers 2.4M (+38% YoY); monthly online rev per sub $84 (+53% YoY).
- Affirms FY2025 revenue guidance $2.3-$2.4B; raises Adj. EBITDA outlook to $295-$335M.
- Introduced 2030 targets of at least $6.5B revenue and $1.3B Adj. EBITDA.
- Gross margin 73% (down 900bps YoY) on GLP-1 mix; partnered with Novo Nordisk for Wegovy access.

## SEC filing metadata
- accession: 0001773751-25-000152
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2025-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000152/0001773751-25-000152-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000152/hims-20250505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-25-000152
- JSON: https://secwatch.observer/filing/0001773751-25-000152.json
- Plain text: https://secwatch.observer/filing/0001773751-25-000152.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.